Radiolabeled peptides belong to a highly specific group of radiotracers used in oncology,
particularly for diagnostics and cancer therapy. With the notable advantages of high binding …

Cancer is currently one of the biggest causes of death in the world. Like some
microorganisms, cancer cells also develop resistance to various chemotherapy drugs and …

Recently, tumor-targeted radionuclide therapy has gained much recognition for the
treatment of metastasized cancer. There is a growing interest in using the theranostic …

Background: Antimicrobial and antifungal activities of Thrombocidin-1 (TC-1) is shown
previously, however, the anti-cancerous feature of this peptide is still uncovered. Objective …

Cancer is considered a global threat to public health as one of the leading causes of
premature deaths in most countries worldwide. Chemotherapy in cancer has reached a …

Radiolabeled peptide could be a useful tool for the diagnosis of non‐small‐cell lung cancer
(NSCLC). In this study, HYNIC‐(Ser) 3‐J18 peptide was labeled with 99mTc using …

A combination of computational techniques has been carried out to predict the binding of
nordentatin derivatives based on pyranocoumarin semi-synthesis with the target protein …

The early diagnosis of non-small cell lung cancer (NSCLC) is important for increasing
survival rate and improving quality life of patients. The aim of this study was to investigate …

Despite the current developments in cancer therapeutics, efforts to excavate new anticancer
agents continue rigorously due to obstacles, such as side effects and drug resistance …

Several anticancer drugs are getting resisted by the cancer cell and treatment like
chemotherapy, radiation causes serious side effects. In immunomodulatory treatment the …